Here’s what you should know:
1. Mr. Hutchison will build the company’s U.S. sales organization and drive prelaunch activities.
2. Motus plans to launch its Pure-Vu colonoscopy preparation system in the U.S. in 2019.
3. Mr. Hutchinson comes to Motus after serving as Bio2 Medical’s vice president of U.S. sales. He also had a tenure at Medtronic GI Solutions.
4. Motus GI CEO Mark Pomeranz said, “Jeff is an experienced and senior sales leader in the GI space who was a key player in the launch and commercial build out of B RRX prior to its acquisition by Covidien as well as its continued growth under Covidien and then Medtronic. He knows how to build and lead a sales organization to drive new market opportunities in the GI space, and that is exactly why he is joining Motus GI now.”
More articles on gastroenterology:
5 tips to cut ASC supply costs
5 most read GI/endoscopy stories August 2 – 8
USA Today, KHN publish follow-up piece on surgery center safety — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.